Keywords
- Papillary Thyroid Carcinoma
- Medullary Thyroid Carcinoma
- Parathyroid Adenoma
- Metastatic Renal Cell Carcinoma
- Hurthle Cell
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Suggested Reading
Erickson LA, Jin L, Goeliner JR, et al. Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid gland. Mod Pathol 2000;13:186.
McHenry CR, Sandoval BA. Management of follicular and Hurthle cell neoplasms of the thyroid gland. Surg Oncol Clin N Am 1998;7:893.
McDonald MP, Sanders LE, Silverman ML, Chan HS, Buyske J. Hurthle cell carcinoma of the thyroid gland: prognostic factors and results of surgical treatment. Surgery (St. Louis) 1996;120:1000.
Renshaw AA. Hurthle cell carcinoma is a better gold standard than Hurthle cell neoplasm for fine-needle aspiration of the thyroid. Cancer Cytopathol 2002;96:261–266.
Yang YJ, Khurana KK. Diagnostic utility of intracytoplasmic lumen and transgressing vessels in evaluation of Hurthle cell lesions by fine-needle aspiration. Arch Pathol Lab Med 2001;125:1031–1035.
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
(2005). Hurthle Cell Lesions. In: Thyroid Cytopathology. Essentials in Cytopathology, vol 1. Springer, New York, NY. https://doi.org/10.1007/0-387-27657-2_7
Download citation
DOI: https://doi.org/10.1007/0-387-27657-2_7
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-23304-8
Online ISBN: 978-0-387-27657-1
eBook Packages: MedicineMedicine (R0)